Viral infections and prolonged fever after liver transplantation in young children with inborn errors of metabolism

Journal of the Formosan Medical Association

Volumn 104, Issue 9, 2005, Pages 623-629

  Huang, Hsiang Po ^a   Chien, Yin Hsiu ^a   Huang, Li Min ^a   Ni, Yen Hsuan ^a   Chang, Mei Hwei ^a   Ho, Ming Chih ^a   Lee, Po Huang ^a   Hwu, Wuh Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytomegalovirus infections, Epstein Barr virus infections; Inborn errors of metabolism; Liver transplantation

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; METHYLMALONIC ACID;

ANAMNESIS; ARTICLE; CASE REPORT; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS; FEMALE; FEVER; FOLLOW UP; HUMAN; INBORN ERROR OF METABOLISM; INFANT; LIVER TRANSPLANTATION; MALE; METHYLMALONIC ACIDEMIA; NEWBORN; ORGAN DONOR; PROTEIN INTAKE; SEROLOGY; VIRUS INFECTION; CYTOMEGALIC INCLUSION BODY DISEASE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; URINE;

CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEVER; HUMANS; INFANT; LIVER TRANSPLANTATION; METABOLISM, INBORN ERRORS; METHYLMALONIC ACID; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; POSTOPERATIVE COMPLICATIONS;

EID: 33644648049     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gartner JC Jr, Zitelli BJ, Malatack JJ, et al: Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics 1984;74:140-5.
2. Largilliere C, Houssin D, Gottrand F, et al: Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr 1989;115:415-7.
3. Todo S, Starzl TE, Tzakis A, et al: Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992;15:419-22.
4. Jan D, Poggi F, Jouvet P, et al: Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. Transplant Proc 1994;26:188.
5. Egawa H, Tanaka K, Inomata Y, et al: Auxiliary partial orthotopic liver transplantation from a living related donor: a report of two cases. Transplant Proc 1996;28:1071-2.
6. Inui A, Fujisawa T, Komatsu H, et al: Histological improvement in native liver after auxiliary partial liver transplantation for ornithine transcarbamylase deficiency. Lancet 1996;348:751-2.
7. Whitington PF, Alonso EM, Boyle JT, et al: Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998;21(Suppl 1):112-8.
8. Leonard JV, Walter JH, McKiernan PJ: The management of organic acidaemias: the role of transplantation. J Inherit Metab Dis 2001;24:309-11.
9. van der Meer SB, Poggi F, Spada M, et al: Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr 1994;125:903-8.
10. Millar AJ, Spearman W, McCulloch M, et al: Liver transplantation for children - the Red Cross Children's Hospital experience. Pediatr Transplant 2004;8:136-44.
11. Bronsther O, Makowka L, Jaffe R, et al: Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988;24:423-34.
12. Kalicinski P, Kaminski A, Prokurat A, et al: Diagnosis and monitoring of cytomegalovirus infection after liver transplantation in children. Ann Transplant 1996;1:13-4.
13. Breinig MK, Zitelli B, Starzl TE, et al: Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987;156:273-9.
14. Bodeus M, Smets F, Reding R, et al: Epstein-Barr virus infection in sixty pediatric liver graft recipients: diagnosis of primary infection and virologic follow-up. Pediatr Infect Dis J 1999;18:698-702.
15. So S. CMV and EBV-PTLD after liver transplantation. Transplant Proc 2001;33:1317-9.
16. Lo YM, Chan LY, Lo KW, et al: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188-91.
17. Huang LM, Lee CY, Chang MH, et al: Primary infections of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6. Arch Dis Child 1993;68:408-11.
18. Lee B, Goss J: Long-term correction of urea cycle disorders. J Pediatr 2001;138:562-71.
19. Fletcher JM, Couper R, Moore D, et al: Liver transplantation for citrullinaemia improves intellectual function. J Inherit Metab Dis 1999;22:581-6.
20. van't Hoff W, McKiernan PJ, Surtees RA, et al: Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 1999;158 (Suppl 2):S70-4.
21. Chakrapani A, Sivakumar P, McKiernan PJ, et al: Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J Pediatr 2002;140:261-3.
22. Nyhan WL, Gargus JJ, Boyle K, et al: Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 2002;161:377-9.
23. Anonymous: 1999 Annual Report of the U. S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data: 1989-1998. U. S. [Annual report]. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; UNOS, Richmond, Virginia, 1999:154-6.
24. Chang FY, Singh N, Gayowski T, et al: Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 1998;26:59-65.
25. Lu SC, Chin LT, Wu FM, et al: Seroprevalence of CMV antibodies in a blood donor population and premature neonate in the south-central Taiwan. Kaohsiung J Med Sci 1999;15:603-10.
26. Tsai WS, Chang MH, Chen JY, et al: Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1989;30:81-6.
27. Sokal EM, Caragiozoglou T, Lamy M, et al: Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993;56:1394-8.
28. Green M, Tzakis A, Reyes J, et al: Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991;6:3038-9.
29. Alessiani M, Kusne S, Martin FM, et al: Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc 1990;1:44-6.
30. Singh N, Mieles L, Yu VL, et al: Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci 1994;39:15-8.
31. Ueda M, Uemoto S, Inomata Y, et al: A proposal of FK506 optimal dosing in living related liver transplantations. Transplantation 1995;60:258-64.
32. Manez R, Breinig MC, Linden P, et al: Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997;176:1462-7.
33. Green M, Kaufmann M, Wilson J, et al: Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997;25:1344-9.